Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Yoshie Nakayama"'
Autor:
Iku Yamaga, Nobuko Kawaguchi-Sakita, Yasufumi Asao, Yoshiaki Matsumoto, Aya Yoshikawa, Toshifumi Fukui, Masahiro Takada, Masako Kataoka, Masahiro Kawashima, Elham Fakhrejahani, Shotaro Kanao, Yoshie Nakayama, Mariko Tokiwa, Masae Torii, Takayuki Yagi, Takaki Sakurai, Hironori Haga, Kaori Togashi, Tsuyoshi Shiina, Masakazu Toi
Publikováno v:
Photoacoustics, Vol 11, Iss , Pp 6-13 (2018)
This study aimed to identify the characteristics of the vascular network in the superficial subcutaneous layer of the breast and to analyze differences between breasts with cancer and contralateral unaffected breasts using vessel branching points (VB
Externí odkaz:
https://doaj.org/article/329975420ed94677b09e92b54a1c2018
Publikováno v:
Case Reports in Oncology, Vol 6, Iss 1, Pp 50-54 (2013)
Background: Bevacizumab has been increasingly used in combination chemotherapy with paclitaxel for treatment of metastatic or recurrent breast cancer. The aim of this report is to underline possible risks associated with the new combination chemother
Externí odkaz:
https://doaj.org/article/773b6e3da848427f8cba96ebbbe8897e
Autor:
Yoshie Nakayama, Mariko Hanada, Hiroshi Koda, Masahiro Sugimoto, Masahiro Takada, Masakazu Toi
Publikováno v:
Journal of Breath Research. 17:016006
This study aimed to evaluate volatile compounds in exhaled breath as a non-invasive screening method to detect breast neoplasms. Exhaled breath samples were collected from patients with breast cancer (BC; n = 45) and non-breast cancer (NBC; n = 51) c
Autor:
Yasufumi Asao, Kaori Togashi, Aya Yoshikawa, Tsuyoshi Shiina, Takayuki Yagi, Yoshiaki Matsumoto, Masahiro Kawashima, Takaki Sakurai, Hironori Haga, Toshifumi Fukui, Masae Torii, Elham Fakhrejahani, Masahiro Takada, Mariko Tokiwa, Masako Kataoka, Masakazu Toi, Nobuko Kawaguchi-Sakita, Shotaro Kanao, Yoshie Nakayama, Iku Yamaga
Publikováno v:
Photoacoustics, Vol 11, Iss, Pp 6-13 (2018)
Photoacoustics
Photoacoustics
This study aimed to identify the characteristics of the vascular network in the superficial subcutaneous layer of the breast and to analyze differences between breasts with cancer and contralateral unaffected breasts using vessel branching points (VB
Publikováno v:
The Journal of Community and Supportive Oncology. 14:210-214
BACKGROUND Chemotherapy with anthracycline- and cyclophosphamide-containing regimens are classified as highly emetogenic. Combinatory treatments of aprepitant (Apr), palonosetron (Pal), or granisetron (Gra) with dexamethasone are recommended as antie
Publikováno v:
Breast Cancer. 22:177-184
Chemotherapy regimens for breast cancer containing anthracycline and cyclophosphamide are classified as highly emetogenic. Aprepitant (A), palonosetron (P), granisetron (G), or dexamethasone (D) are recommended antiemetic drugs. However, it is uncert
Publikováno v:
Case Reports in Oncology, Vol 6, Iss 1, Pp 50-54 (2013)
Case Reports in Oncology
Case Reports in Oncology
Background: Bevacizumab has been increasingly used in combination chemotherapy with paclitaxel for treatment of metastatic or recurrent breast cancer. The aim of this report is to underline possible risks associated with the new combination chemother
Autor:
Akiko Kuwayama, Masaru Oba, Chie Watanabe, Kiyohiko Hatake, Kyoko Masumura, Kenichi Inoue, Shunji Takahashi, Kokoro Kobayashi, Chizuko Tsutsumi, Yoshie Nakayama, Yoshinori Ito, Masafumi Oto, Shinichiro Taira, Nahomi Tokudome
Publikováno v:
Breast Cancer. 18:195-202
Circulating tumor cells (CTCs) are detected in peripheral blood of breast cancer patients, and they may play an important role as a prognostic and predictive marker. We conducted this study to determine the presence of CTCs with the CellSearch System
Autor:
C. Tsutsumi, Takayuki Kobayashi, Kiyohiko Hatake, Yoshie Nakayama, Yoshinori Ito, Y. Kawai, Ippei Fukada, Kokoro Kobayashi, S. Takahashi
Publikováno v:
Annals of Oncology. 23:xi126-xi127
Background and objective The important characteristics of breast cancer is its heterogeneity and attitude of response to neoadjuvant chemotherapy (NAC). We analyzed the patterns of tumor shrinkage as a prognostic indicator after NAC for luminal breas
Publikováno v:
Journal of Clinical Oncology. 31:e22027-e22027
e22027 Background: The neoadjuvant use of bisphosphonates has been reported to increase rates of pathological response in patients with operable breast cancer. We conducted a study to determine whether treatment with zoledronic acid (ZOL) would impro